Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Caroline Shepherd
Caroline Shepherd, BPharm, is Managing Scientific Director, for McCann Health Medical Communications Ltd, with over 25 years’ experience in global communications and medical publications strategy in Medical Affairs for the biopharmaceutical industry. Caroline leads teams in delivering scientific excellence and has led and executed a variety of medical communications programs in numerous therapeutic domains. Research interests have included the value of professional medical writers, plain language summaries and scientific accuracy in lay media. Most recently, Caroline has joined the inaugural MAPS Editorial Review Board where she is delighted to be applying her medical publications experience to uphold excellence and credibility of MAPS publications.
Caroline received a bachelor’s degree in Pharmacy (BPharm) from the University of London and is an International Society for Medical Publications Professionals (ISMPP) Certified Medical Publications Professional (CMPP).
Joanna Zhang
10 years clinician experience as Medical Doctor after graduated from Medical University. Deep Involved clinical research & development, Virus & Immunology, Infectious disease prevent & control. Published abundant scientific papers in international & National Medical Journals.
20 years experience on the multi-functional roles of medical related, e.g. Medical, Clinical, Regulatory and even Government Affairs at top Multinational Pharmaceutical Industries. As the position of head of Medical in China & North Asia region of global Medical organization. Broad category on oncology, chronic disease, diabetes, gastrology and vaccine, etc.
As the core member of Medical sub-group of RDPAC, faculty member of China Medical Affairs committee. As the reviewer of the book《Medical Science Driven》《Digital Medical》《Post Market Clinical Practice Guidance》. Working as the Vice General Manager of Hengrui Pharmaceutical Company, Head of central Medical Affairs Department.
Tamas Koncz
Tamas Koncz, MD, MSc, Ph.D., is Chief Medical Officer (CMO) for the Inflammation and Immunology (I&I) Business at Pfizer. As CMO, Tamas leads the medical affairs organization, medical professionals across the world who are responsible for ensuring the safe and effective use of Pfizer I&I medicines, as well as continuous data generation and dissemination to advance the understanding of the medicines’ benefit: risk profiles. Medical affair colleagues are also involved in projects supporting research and early and late phase development, regulatory affairs, reimbursement and lifecycle management of the medicines. Throughout his career, Tamas has held various roles as a VP Global TA Lead, Global and European Medical Director, UK country medical adviser, health economist working with a broad portfolio and medical devices. Tamas holds an MD from the University of Debrecen, Hungary. Additionally, he completed an MSc in Economics at the Corvinus University, Budapest, an MSc in Health Economics at the University of York, UK and an MSc in Pharmaceutical Medicine at the University of Surrey, UK. Tamas also holds a Ph.D. from Semmelweis University, Hungary.
